Without big Medicare insurers, the future of program to cover popular obesity drugs had been in question.

The deal involves Regeneron lowering the prices of all its current and future drugs on Medicaid, according to Trump. It also ...

Demand for weight loss drugs is ballooning across the U.S. — and Amazon wants in. The Seattle-based tech giant launched its ...

Medicare delayed a plan to make insurance companies cover GLP-1 drugs Wegovy and Zepbound. Instead, Medicare will cover the ...

The drug company is the 17th to agree to lower its prices as part of the administration’s Most Favored Nation initiative. It ...

The 340B Drug Pricing Program must be reformed to better patient health and disincentivize institutional profit-seeking ...

B makes it possible for community health organizations to stretch scarce resources and reinvest savings where they belong — ...

Regeneron is the latest in a string of major drugmakers to make pricing concessions for new and existing medicines under ...

Amazon One Medical members can get Novo Nordisk’s Wegovy and Eli Lilly’s Foundayo GLP-1 pills in a program that integrates ...

The order signed by Todd Blanche does not legalize marijuana for medical or recreational use under federal law. But it does ...

Through Amazon Pharmacy, patients will be able to access medications including Novo Nordisk's Wegovy as well as newer oral ...